Physician profile
James D Baker
NPI 1588879860
$40,105.71
in general payments reported to CMS, 2019-2025
9 companies · $9,199 in 2025
The $9,199 reported for 2025 was more than what 92% of Hand Surgery providers received nationally (typical 2025 total: $270).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14K · 2020: $45.07 · 2021: $2,212 · 2022: $4,641 · 2023: $7,643 · 2024: $2,209 · 2025: $9,199.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $15K · Food and Beverage: $2,357 · Travel and Lodging: $1,994.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $14,700.00 |
| Food and Beverage | $2,356.86 |
| Travel and Lodging | $1,994.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Skeletal Dynamics INC | $27,946.89 | 2019-2025 | Align, Implate, Geminus |
| Stryker Corporation | $7,494.60 | 2021-2025 | Mako, Triathlon, Makoplasty |
| Advanced Orthopaedic Solutions, INC. | $1,911.33 | 2019 | |
| Zimmer Biomet Holdings, INC. | $1,802.77 | 2019-2025 | Persona, Affixus, Comprehensive Shoulder System |
| Anika Therapeutics, INC. | $705.37 | 2021-2022 | |
| Ethicon US, LLC | $189.56 | 2022-2025 | Vistaseal, Ethicon |
| Medtronic, INC. | $20.94 | 2024 | Aquamantys(Tm) |
| Axogen | $19.68 | 2020 | |
| Melinta Therapeutics, LLC | $14.57 | 2023 | Orbactiv, Kimyrsa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Baker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.